|
||||
|
||||
The Globalization of Innovation: Pharmaceuticals: Can India and China Cure the Global Pharmaceutical Market
Vivek Wadhwa Duke University - Pratt School of Engineering; Harvard University - Labor and Worklife Program Ben Rissing Harvard Law School - Labor and Worklife Program; Duke University - Pratt School of Engineering - Master of Engineering Management Program Gary Gereffi Duke University - Department of Sociology - Director, Center on Globalization, Governance & Competitiveness John Trumpbour Harvard University - Labor and Worklife Program Pete Engardio BusinessWeek Abstract: Multinational pharmaceutical corporations are searching for means to broaden their capacity for drug development while decreasing costs. Pharmaceutical firms in India and China are increasingly forging partnerships with these corporations to gain revenue and to develop their own expertise. These relationships largely appear to be symbiotic. As a result of the movement of research to their countries, Indian and Chinese scientists are rapidly developing the ability to innovate and create their own intellectual property. Several firms in India and China are performing advanced R&D and are moving into the highest-value segments of the pharmaceutical global value chain.
Keywords: pharmaceuticals, innovaiton, R&D, value chain, China, India Working Paper SeriesDate posted: June 11, 2008 ; Last revised: June 18, 2008Suggested CitationContact Information
|
|
||||||||||||||||||||||
© 2009 Social Science Electronic Publishing, Inc. All Rights Reserved. Terms of Use Privacy Policy
This page was served by apollo2 in 0.141 seconds.